{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:53:24Z","timestamp":1781852004908,"version":"3.54.5"},"reference-count":45,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15643","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:18:31Z","timestamp":1778242711000},"page":"1-10","source":"Crossref","is-referenced-by-count":0,"title":["Meta\u2011analysis of efficacy comparisons between standard\u2011 and low\u2011dose Bacillus Calmette\u2011Guerin vaccines in managing non\u2011muscular invasive bladder cancer"],"prefix":"10.3892","volume":"32","author":[{"given":"Xiaoxi","family":"Liu","sequence":"first","affiliation":[{"name":"Operating Room, West China Hospital, Sichuan University Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yige","family":"Bao","sequence":"additional","affiliation":[{"name":"Operating Room, West China Hospital, Sichuan University Chengdu, Sichuan 610041, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"key20260619091658_b1-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"key20260619091658_b2-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskj\u00f8t","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"key20260619091658_b3-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"3782","DOI":"10.21037\/tau-2025-661","article-title":"Global insights into the management of BCG-unresponsive non-muscle invasive bladder cancer: A narrative review of provider surveys","volume":"14","author":"Abou Chakra","year":"2025","journal-title":"Transl Androl Urol"},{"key":"key20260619091658_b4-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur Urol"},{"key":"key20260619091658_b5-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/curroncol31020079","article-title":"BCG and alternative therapies to BCG therapy for Non-Muscle-Invasive bladder cancer","volume":"31","author":"Lidagoster","year":"2024","journal-title":"Curr Oncol"},{"key":"key20260619091658_b6-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on Non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"key20260619091658_b7-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"eabn4118","DOI":"10.1126\/scitranslmed.abn4118","article-title":"Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Gu\u00e9rin","volume":"15","author":"de Jong","year":"2023","journal-title":"Sci Transl Med"},{"key":"key20260619091658_b8-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.urology.2020.10.039","article-title":"Side effects of intravesical BCG and chemotherapy for bladder cancer: What they are and how to manage them","volume":"149","author":"Koch","year":"2021","journal-title":"Urology"},{"key":"key20260619091658_b9-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.3390\/jcm13072031","article-title":"Treating BCG-Induced cystitis with combined chondroitin and hyaluronic acid instillations in bladder cancer","volume":"13","author":"Pichler","year":"2024","journal-title":"J Clin Med"},{"key":"key20260619091658_b10-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.eururo.2014.11.031","article-title":"Therapeutic options in high-risk non-muscle-invasive bladder cancer during the current worldwide shortage of bacille Calmette-Gu\u00e9rin","volume":"67","author":"Mostafid","year":"2015","journal-title":"Eur Urol"},{"key":"key20260619091658_b11-ol-32-1-15643","article-title":"Sanofi's halt of BCG production worries bladder cancer patients and urologists","author":"Katz"},{"key":"key20260619091658_b12-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/imt-2022-0309","article-title":"Low-dose or -number of BCG in non-muscle invasive bladder cancer: Updated systematic review and meta-analysis","volume":"15","author":"Kawada","year":"2023","journal-title":"Immunotherapy"},{"key":"key20260619091658_b13-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4111\/icu.20210340","article-title":"Low-dose versus standard-dose bacille Calmette-Gu\u00e9rin for non-muscle-invasive bladder cancer: Systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Choi","year":"2022","journal-title":"Investig Clin Urol"},{"key":"key20260619091658_b14-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.urolonc.2023.04.003","article-title":"The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis","volume":"41","author":"Kawada","year":"2023","journal-title":"Urol Oncol"},{"key":"key20260619091658_b15-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"key20260619091658_b16-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: A critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea","year":"2017","journal-title":"BMJ"},{"key":"key20260619091658_b17-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"key20260619091658_b18-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.pu.09.050188.001011","article-title":"A general overview of Mantel-Haenszel methods: Applications and recent developments","volume":"9","author":"Kuritz","year":"1988","journal-title":"Annu Rev Public Health"},{"key":"key20260619091658_b19-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1177\/0962280210392008","article-title":"Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A comparison between DerSimonian-Laird and restricted maximum likelihood","volume":"21","author":"Kontopantelis","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"key20260619091658_b20-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0022-5347(17)37532-8","article-title":"Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer","volume":"147","author":"Morales","year":"1992","journal-title":"J Urol"},{"key":"key20260619091658_b21-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF02550276","article-title":"Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer","volume":"30","author":"Yal\u00e7inkaya","year":"1998","journal-title":"Int Urol Nephrol"},{"key":"key20260619091658_b22-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1097\/00005392-200211000-00104","article-title":"Urinary interleukin-8 predicts the response of standard and low dose intravesical bacillus Calmette-Guerin (modified Danish 1331 strain) for superficial bladder cancer","volume":"168","author":"Kumar","year":"2002","journal-title":"J Urol"},{"key":"key20260619091658_b23-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1046\/j.1464-410X.2002.02722.x","article-title":"Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Gu\u00e9rin with a reduced dose of 27 mg in superficial bladder cancer","volume":"89","author":"Mart\u00ednez-Pi\u00f1eiro","year":"2002","journal-title":"BJU Int"},{"key":"key20260619091658_b24-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.0919-8172.2003.00607.x","article-title":"Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus CalmetteGu\u00e9rin for superficial bladder cancer recurrence","volume":"10","author":"Irie","year":"2003","journal-title":"Int J Urol"},{"key":"key20260619091658_b25-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1097\/01.ju.0000173919.28835.aa","article-title":"Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial","volume":"174","author":"Mart\u00ednez-Pi\u00f1eiro","year":"2005","journal-title":"J Urol"},{"key":"key20260619091658_b26-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"317","DOI":"10.4103\/0970-1591.29117","article-title":"A randomized trial comparing low dose (40 or 80 mg) with standard dose (120 mg) of bacillus Calmette-Guerin for superficial bladder cancer","volume":"22","author":"Vijjan","year":"2006","journal-title":"Indian J Urol"},{"key":"key20260619091658_b27-ol-32-1-15643","first-page":"360","article-title":"Immunization & Side Effect Comparison of BCG Intracavitary Perfusion at Different Dose for Patients with Bladder Carcinoma After Surgery","author":"Liu","year":"2007","journal-title":"China Pharmacy"},{"key":"key20260619091658_b28-ol-32-1-15643","first-page":"513","article-title":"Effect of low dose bacillus Calmette-Guerin intravesical instillation against recurrence of superficial bladder cancer","volume":"46","author":"Zhang","year":"2008","journal-title":"J Shandong Univ (Health Sciences)"},{"key":"key20260619091658_b29-ol-32-1-15643","first-page":"279","article-title":"Comparison of the effect of intro vesical instillation of different dose for superficial TCC","volume":"13","author":"Zheng","year":"2008","journal-title":"Xiandai Miniao Waike Zaxhi"},{"key":"key20260619091658_b30-ol-32-1-15643","first-page":"1357","article-title":"Clinical observation of bladder perfusion with different doses of BCG vaccine in treatment of superficial bladder cancer","volume":"18","author":"Gong","year":"2009","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"key20260619091658_b31-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/0974-7796.106873","article-title":"Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Gu\u00e9rin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective comparison","volume":"5","author":"Inamoto","year":"2013","journal-title":"Urol Ann"},{"key":"key20260619091658_b32-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.juro.2015.08.075","article-title":"Randomized controlled study of the efficacy, safety and quality of life with low dose bacillus Calmette-gu\u00e9rin instillation therapy for nonmuscle invasive bladder cancer","volume":"195","author":"Yokomizo","year":"2016","journal-title":"J Urol"},{"key":"key20260619091658_b33-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1186\/s12885-023-11605-8","article-title":"Protocol of the comparison of intravesical therapy and surgery as treatment options (CISTO) study: A pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer","volume":"23","author":"Gore","year":"2023","journal-title":"BMC Cancer"},{"key":"key20260619091658_b34-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1200\/JCO-25-01324","article-title":"Twelve-month results from the CISTO study comparing radical cystectomy versus Bladder-sparing therapy for recurrent High-Grade Non-Muscle-invasive bladder cancer","volume":"44","author":"Gore","year":"2026","journal-title":"J Clin Oncol"},{"key":"key20260619091658_b35-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/brainsci14121203","article-title":"Peripheral mechanisms underlying bacillus Calmette-Guerin-Induced lower urinary tract symptoms (LUTS)","volume":"14","author":"Elmasri","year":"2024","journal-title":"Brain Sci"},{"key":"key20260619091658_b36-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1327053","DOI":"10.3389\/fnins.2023.1327053","article-title":"BCG induced lower urinary tract symptoms during treatment for NMIBC-Mechanisms and management strategies","volume":"17","author":"Bourlotos","year":"2024","journal-title":"Front Neurosci"},{"key":"key20260619091658_b37-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"e779","DOI":"10.1016\/j.clgc.2019.04.003","article-title":"Moreau strain bacillus Calmette-gu\u00e9rin low versus standard dose in the treatment of High-Grade T1 bladder cancer: A retrospective observational cohort study","volume":"17","author":"Carneiro","year":"2019","journal-title":"Clin Genitourin Cancer"},{"key":"key20260619091658_b38-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"e8300","DOI":"10.1097\/MD.0000000000008300","article-title":"Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials","volume":"96","author":"Quan","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"key20260619091658_b39-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"key20260619091658_b40-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus CalmetteGuerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"key20260619091658_b41-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.7314\/APJCP.2014.15.3.1321","article-title":"Effect of TLR4 and B7-H1 on immune escape of urothelial bladder cancer and its clinical significance","volume":"15","author":"Wang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20260619091658_b42-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2147\/OTT.S294129","article-title":"Remodels the immunosuppressive tumor microenvironment by combination of bacillus Calmette-Gu\u00e9rin and anti-PD-L1 in an orthotopic triple-negative breast cancer mouse model","volume":"14","author":"Lu","year":"2021","journal-title":"Onco Targets Ther"},{"key":"key20260619091658_b43-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.2147\/IJN.S216432","article-title":"Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel","volume":"14","author":"Yoon","year":"2019","journal-title":"Int J Nano medicine"},{"key":"key20260619091658_b44-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"16774","DOI":"10.1016\/j.bbrc.2018.12.097","article-title":"The immunotherapeutic effects of recombinant Bacillus Calmette-Gu\u00e9rin resistant to antimicrobial peptides on bladder cancer cells","volume":"509","author":"Cho","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"key20260619091658_b45-ol-32-1-15643","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.3390\/cancers12123679","article-title":"Liposome-encapsulated bacillus Calmette-Gu\u00e9rin cell wall skeleton enhances antitumor efficiency for bladder cancer in vitro and in vivo via induction of AMP-activated protein kinase","volume":"12","author":"Whang","year":"2020","journal-title":"Cancers (Basel)"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:17:02Z","timestamp":1781849822000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,8]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15643","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]}}}